Ghent University Academic Bibliography

Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations

Pieter-Jan De Sutter (UGent) , Evelyn Dhont (UGent) , Daphne Vens, Peter De Paepe (UGent) , Jef Willems (UGent) , Petra Schelstraete (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter De Cock (UGent)

(2026) CLINICAL MICROBIOLOGY AND INFECTION. 32(2). p.266-271

Add to list

Journal Article
A1
open access

Dose-limiting toxicities of paclitaxel in breast cancer patients : studying interactions between pharmacokinetics, physical activity, and body composition : a protocol for an observational cohort study

Len De Nys, Anita Barzegar-Fallah, Katrien Lanckmans, Stephane Steurbaut, David Beckwée, Amy de Haar-Holleman, Steven Provyn, Elke Gasthuys (UGent) , Sofie Vande Casteele (UGent) , Pieter-Jan De Sutter (UGent) , et al.

(2025) CANCERS. 17(1).

Add to list

Understanding meropenem disposition in critically ill children : a population PK analysis

Thi Van Anh Nguyen (UGent) , Evelyn Dhont (UGent) , Emma Beel (UGent) , Nick Verougstraete (UGent) , Veronique Stove (UGent) , Sophie Vanhaesebrouck (UGent) , Daphne Vens, Peter De Paepe (UGent) , Pieter De Cock (UGent) and An Vermeulen (UGent)

(2025) Abstract Book 2025 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases. p.2877-2877

Add to list

Under the magnifying glass : investigating aflatoxin B1 and efavirenz in mycotoxin-drug interactions

Orphélie Lootens (UGent) , An Vermeulen (UGent) , Marthe De Boevre (UGent) and Sarah De Saeger (UGent)

(2025) Food Contaminants, 6th International Conference, Abstracts.

Add to list

Synergy of body composition, exercise oncology, and pharmacokinetics : a narrative review of personalizing paclitaxel treatment for breast cancer

Nele Adriaenssens, Stephanie C. M. Wuyts, Stephane Steurbaut, Pieter-Jan De Sutter (UGent) , An Vermeulen (UGent) , Amy de Haar-Holleman, David Beckwée, Steven Provyn, Sofie Vande Casteele (UGent) , Jinyu Zhou, et al.

(2025) CANCERS. 17(8).

Add to list

Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations

Pieter-Jan De Sutter (UGent) , Evelyn Dhont (UGent) , Daphné Vens, Peter De Paepe (UGent) , Jef Willems (UGent) , Petra Schelstraete (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) and Pieter De Cock (UGent)

(2025) European Society for Developmental, Perinatal and Paediatric Pharmacology (ESDPPP), 21st Congress, Abstracts. In Pediatric Drugs 27(4). p.518-519

Add to list

Journal Article
A1
open access

Second-generation AURKA-targeting PROTACs : structural optimization toward in vivo degradation in neuroblastoma

Simon Krols (UGent) , Muhammad Rishfi (UGent) , Fien Martens (UGent) , Anouk Van Hauwermeiren (UGent) , Ellen Sanders (UGent) , Pieter-Jan De Sutter (UGent) , An Vermeulen (UGent) , Kaat De Wever (UGent) , Sarah-Lee Bekaert (UGent) , M. Emmy M. Dolman, et al.

(2025) JOURNAL OF MEDICINAL CHEMISTRY. 68(22). p.23962-23976

Add to list

Journal Article
A1
open access

Building Sub-Saharan African PBPK populations reveals critical data gaps : a case study on Aflatoxin B1

Orphélie Lootens (UGent) , Marthe De Boevre (UGent) , Sarah De Saeger (UGent) , Jan Van Bocxlaer (UGent) and An Vermeulen (UGent)

(2025) TOXINS. 17(10).

Add to list

Intraperitoneal aerosolized nanoliposomal irinotecan in patients with peritoneal metastases : preliminary pharmacokinetic results from a phase I trial

Judith van Ovost (UGent) , Pieter-Jan De Sutter (UGent) , Sarah Cosyns (UGent) , Sofie Vande Casteele (UGent) , Jan Van Bocxlaer (UGent) , An Vermeulen (UGent) , Wouter Willaert (UGent) and Wim Ceelen (UGent)

(2025) EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. In European Journal of Surgical Oncology 51(Supplement 2). p.15-16

Add to list

Miscellaneous
open access

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death (vol 13, 1046, 2025)

Samya Van Coillie, Emily Van San, Ines Goetschalckx, Bartosz Wiernicki, Banibrata Mukhopadhyay, Wulf Tonnus, Sze Men Choi, Ria Roelandt (UGent) , Catalina Dumitrascu, Ludwig Lamberts, et al.

(2025) NATURE COMMUNICATIONS. 16(1).

Academic Bibliography

Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations

Dose-limiting toxicities of paclitaxel in breast cancer patients : studying interactions between pharmacokinetics, physical activity, and body composition : a protocol for an observational cohort study

Understanding meropenem disposition in critically ill children : a population PK analysis

Under the magnifying glass : investigating aflatoxin B1 and efavirenz in mycotoxin-drug interactions

Synergy of body composition, exercise oncology, and pharmacokinetics : a narrative review of personalizing paclitaxel treatment for breast cancer

Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations

Second-generation AURKA-targeting PROTACs : structural optimization toward in vivo degradation in neuroblastoma

Building Sub-Saharan African PBPK populations reveals critical data gaps : a case study on Aflatoxin B1

Intraperitoneal aerosolized nanoliposomal irinotecan in patients with peritoneal metastases : preliminary pharmacokinetic results from a phase I trial

Targeting ferroptosis protects against experimental (multi)organ dysfunction and death (vol 13, 1046, 2025)

Contents

Support

Contact